Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

FDA approves IND for anti-GM-CSF monoclonal antibody TJM2

Dec. 24, 2018

Phase II study of zilucoplan in gMG meets primary and key secondary endpoints

Dec. 11, 2018

Positive preliminary phase I data presented for TransCon CNP

Nov. 30, 2018

Takeda describes new BRD4 BD2 domain inhibitors

Nov. 30, 2018

Phase III results of the IL-17A antagonist ixekizumab for radiographic axial spondyloarthritis

Nov. 8, 2018

FDA approves adalimumab biosimilar Hyrimoz

Nov. 5, 2018

ASP-5094 safe and well tolerated in patients with rheumatoid arthritis on methotrexate

Oct. 29, 2018

Dual ICOS/CD28 antagonist demonstrates efficacy in models of autoimmune disease

Oct. 29, 2018

SpinalCyte presents 12-month data from phase I/II study of CybroCell in degenerative disc disease

Oct. 26, 2018

Phase IIb study of SM-04690 in knee osteoarthritis meets primary endpoints

Oct. 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...